Accessibility Menu
 
Arrow-Thin-Down
S&P 500
7,400.96
-0.2%
-11.88
Arrow-Thin-Down
DJI
49,760.56
+0.1%
+56.09
Arrow-Thin-Down
NASDAQ
26,088.20
-0.7%
-185.92
Arrow-Thin-Down
Bitcoin
$80,630.00
-1.4%
-$1,106.43
Arrow-Thin-Down
AAPL
$294.83
+0.7%
+$2.15
Arrow-Thin-Down
AMZN
$265.79
-1.2%
-$3.20
Arrow-Thin-Down
GOOG
$383.99
-0.7%
-$2.78
Arrow-Thin-Down
META
$603.12
+0.7%
+$4.26
Arrow-Thin-Down
MSFT
$407.68
-1.2%
-$4.98
Arrow-Thin-Down
NVDA
$220.85
+0.6%
+$1.41
Arrow-Thin-Down
TSLA
$433.45
-2.6%
-$11.55
Most Active StocksDaily Stock GainersDaily Stock Losers

2 Fantastic Beaten-Down Growth Stocks Down 40% and 45% to Buy

These two stocks are poised for near-term and long-term upside.

By Neil Rozenbaum – May 20, 2025 at 10:53AM EST

In this video, I'll highlight two promising companies that could be great long-term investments, even in today's volatile market. Watch the short video to learn more, consider subscribing, and click the special offer link below.

*Stock prices used were from the trading day of May 19, 2025. The video was published on May 19, 2025.

Read Next

Neil Rozenbaum has no position in any of the stocks mentioned. The Motley Fool recommends Evolution AB and Novo Nordisk. The Motley Fool has a disclosure policy. Neil is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.

Stocks Mentioned

Novo Nordisk Stock Quote
Novo Nordisk
NYSE: NVO
$47.00
(+1.29%)+$0.60
Evolution AB Stock Quote
Evolution AB
OTC: EVVTY
$68.33
(+2.26%)+$1.51

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services